Intravitreal Dexamethasone Implant in Autoimmune Retinopathy
Purpose. To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). Methods. Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. Result...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2023-01-01
|
| Series: | Case Reports in Ophthalmological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2023/5670538 |
| _version_ | 1797850569517301760 |
|---|---|
| author | Fernando Longhi Bordin Carolina da Silva Mengue Manuel Augusto Pereira Vilela |
| author_facet | Fernando Longhi Bordin Carolina da Silva Mengue Manuel Augusto Pereira Vilela |
| author_sort | Fernando Longhi Bordin |
| collection | DOAJ |
| description | Purpose. To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). Methods. Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. Results. The patients showed an interruption of the functional losses and remained stable with semestral injections. Conclusion. AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option. |
| first_indexed | 2024-04-09T19:02:29Z |
| format | Article |
| id | doaj.art-570ab5aba7154449a1ea867423ee6f34 |
| institution | Directory Open Access Journal |
| issn | 2090-6730 |
| language | English |
| last_indexed | 2024-04-09T19:02:29Z |
| publishDate | 2023-01-01 |
| publisher | Hindawi Limited |
| record_format | Article |
| series | Case Reports in Ophthalmological Medicine |
| spelling | doaj.art-570ab5aba7154449a1ea867423ee6f342023-04-08T00:00:06ZengHindawi LimitedCase Reports in Ophthalmological Medicine2090-67302023-01-01202310.1155/2023/5670538Intravitreal Dexamethasone Implant in Autoimmune RetinopathyFernando Longhi Bordin0Carolina da Silva Mengue1Manuel Augusto Pereira Vilela2Institute Ivo Corrêa-MeyerInstitute Ivo Corrêa-MeyerFederal University of Health Sciences of Porto AlegrePurpose. To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). Methods. Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. Results. The patients showed an interruption of the functional losses and remained stable with semestral injections. Conclusion. AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option.http://dx.doi.org/10.1155/2023/5670538 |
| spellingShingle | Fernando Longhi Bordin Carolina da Silva Mengue Manuel Augusto Pereira Vilela Intravitreal Dexamethasone Implant in Autoimmune Retinopathy Case Reports in Ophthalmological Medicine |
| title | Intravitreal Dexamethasone Implant in Autoimmune Retinopathy |
| title_full | Intravitreal Dexamethasone Implant in Autoimmune Retinopathy |
| title_fullStr | Intravitreal Dexamethasone Implant in Autoimmune Retinopathy |
| title_full_unstemmed | Intravitreal Dexamethasone Implant in Autoimmune Retinopathy |
| title_short | Intravitreal Dexamethasone Implant in Autoimmune Retinopathy |
| title_sort | intravitreal dexamethasone implant in autoimmune retinopathy |
| url | http://dx.doi.org/10.1155/2023/5670538 |
| work_keys_str_mv | AT fernandolonghibordin intravitrealdexamethasoneimplantinautoimmuneretinopathy AT carolinadasilvamengue intravitrealdexamethasoneimplantinautoimmuneretinopathy AT manuelaugustopereiravilela intravitrealdexamethasoneimplantinautoimmuneretinopathy |